3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Classical hematology
1
Breast
1
Conditions
Neoplasms
2
Venous Thrombosis
1
Venous Thromboembolism
1
Vascular Diseases
1
Urogenital Neoplasms
1
Thromboembolism
1
Pulmonary Embolism
1
Prostatic Neoplasms
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphatic Diseases
1
Lung Neoplasms
1
Leukemia
1
Intestinal Neoplasms
1
Hemostatic Disorders
1
Digestive System Neoplasms
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
Gene Expression Profiling
11
Surveys and Questionnaires
9
Polymerase Chain Reaction
9
Immunohistochemistry
9
Amplified Fragment Length Polymorphism Analysis
9
Flow Cytometry
8
Psychiatric Rehabilitation
7
Microarray Analysis
6
Rituximab
5
Interviews as Topic
4
Cytogenetic Analysis
4
Blood Specimen Collection
4
Biopsy
4
Therapeutics
3
Immunologic Techniques
3
Gene Rearrangement
3
Drug Therapy
3
Doxorubicin
3
Data Collection
3
Cyclophosphamide
3
plerixafor
2
Vincristine
2
Prednisone
2
Positron-Emission Tomography
2
Phlebotomy
2
Pharmacogenomic Testing
2
Observation
2
Neuropsychological Tests
2
Mental Status and Dementia Tests
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lymphoma
×
Tinzaparin
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled